Inveni

InveniAI is a global leader in pioneering the application of artificial intelligence and machine learning to transform innovation in the life sciences industry. The company utilizes its proprietary AI platform, AlphaMeld, to identify and accelerate the development of high-value drug candidates and therapeutic opportunities by analyzing vast datasets of scientific and clinical information. By integrating multi-omics data with clinical and regulatory insights, InveniAI helps its partners de-risk drug discovery and optimize portfolio management. The company operates through a hybrid model of internal pipeline development and strategic collaborations with major pharmaceutical companies to address unmet medical needs across various therapeutic areas.